Variant report
Variant | rs28615951 |
---|---|
Chromosome Location | chr9:98196823-98196824 |
allele | A/C |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:98189400-98197400 | Weak transcription | Brain Hippocampus Middle | brain |
2 | chr9:98189600-98210800 | Weak transcription | Right Atrium | heart |
3 | chr9:98189800-98206600 | Weak transcription | Pancreas | Pancrea |
4 | chr9:98193800-98197800 | Enhancers | Fetal Heart | heart |
5 | chr9:98194800-98206600 | Weak transcription | Left Ventricle | heart |
6 | chr9:98196000-98200600 | Weak transcription | Brain Germinal Matrix | brain |
7 | chr9:98196400-98197000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
8 | chr9:98196400-98197000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr9:98196400-98197000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr9:98196400-98197000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr9:98196400-98197000 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr9:98196400-98197000 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr9:98196400-98197000 | Flanking Active TSS | HepG2 | liver |
14 | chr9:98196400-98197200 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
15 | chr9:98196400-98197200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr9:98196400-98197200 | Enhancers | Placenta | Placenta |
17 | chr9:98196400-98197400 | Flanking Active TSS | K562 | blood |
18 | chr9:98196600-98197000 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
19 | chr9:98196600-98197200 | Enhancers | H1 Cell Line | embryonic stem cell |
20 | chr9:98196600-98197200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr9:98196600-98197200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
22 | chr9:98196600-98197200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr9:98196600-98197200 | Enhancers | Fetal Lung | lung |
24 | chr9:98196600-98197200 | Enhancers | Fetal Stomach | stomach |
25 | chr9:98196600-98197400 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
26 | chr9:98196800-98197000 | Flanking Bivalent TSS/Enh | HUES48 Cell Line | embryonic stem cell |
27 | chr9:98196800-98197000 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
28 | chr9:98196800-98197000 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
29 | chr9:98196800-98197000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
30 | chr9:98196800-98197200 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
31 | chr9:98196800-98197200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
32 | chr9:98196800-98197200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
33 | chr9:98196800-98197200 | Enhancers | H9 Cell Line | embryonic stem cell |
34 | chr9:98196800-98197200 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
35 | chr9:98196800-98206600 | Weak transcription | Fetal Muscle Leg | muscle |
36 | chr9:98196800-98207000 | Weak transcription | Primary T cells fromperipheralblood | blood |